AngioDynamics, Inc. (ANGO) Financials
ANGO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-02-29 | 323.6 million | 107.6 million |
2023-11-30 | 499.6 million | 98.4 million |
2023-08-31 | 493.9 million | 66.1 million |
2023-05-31 | 532.6 million | 154.3 million |
ANGO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-02-29 | -13.1 million | 2.6 million |
2023-11-30 | 4.7 million | 1.9 million |
2023-08-31 | -26.7 million | 4.1 million |
2023-05-31 | 14.9 million | 3.0 million |
ANGO Net Income
No data available :(
ANGO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-02-29 | 78.5 million | - | - |
2023-11-30 | 60.9 million | - | - |
2023-08-31 | 57.6 million | - | - |
2023-05-31 | 44.6 million | 49.8 million | - |
ANGO Shares Outstanding
ANGO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-02-29 | 607000 | 8.2 million | 10.6 million | 25.4 million |
2023-11-30 | 554000 | 8.7 million | 9.3 million | 25.5 million |
2023-08-31 | 791000 | 7.9 million | 10.9 million | 27.4 million |
2023-05-31 | 1.1 million | 7.9 million | 10.2 million | 26.3 million |
ANGO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-02-29 | 75.2 million | 42.6 million |
2023-11-30 | 79.1 million | 38.8 million |
2023-08-31 | 78.7 million | 38.6 million |
2023-05-31 | 91.1 million | 44.7 million |
ANGO
Price: $6.27
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.36 USD
P/E Ratio: -17.08
Exchange: NMS
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 233107
Ebitda: 7.0 millionMarket Capitalization: 277.8 million